Section 15-1003 - [Abrogated 10/1/2030] General consideration(a) The Program shall: (1) Provide a prescription drug benefit subsidy, as determined by the Department, that may pay all or some of the deductibles, coinsurance payments, premiums, and copayments under the federal Medicare Part D Pharmaceutical Assistance Program for enrollees of the Program; and(2) Provide the subsidy to the maximum number of individuals eligible for enrollment in the Program, subject to the money available in the Fund.(b) The Program may limit payment of any subsidy by paying the subsidy only on behalf of eligible individuals enrolled in a Medicare Part D Prescription Drug Plan or Medicare Advantage Plan that coordinates with the Program in accordance with federal requirements.(c) The Program may annually provide an additional subsidy, up to the full amount of the Medicare Part D Prescription Drug Plan premium, for individuals who qualify for a partial federal low-income subsidy.(d) The Department shall maintain a waiting list of individuals who meet the eligibility requirements for the Program but who are not served by the Program due to funding limitations.(e) The Department shall determine annually:(1) The number of individuals to be enrolled in the Program;(2) The amount of subsidy to be provided under subsection (a) of this section; and(3) The amount of any additional subsidy provided under subsection (c) of this section.Amended by 2024 Md. Laws, Ch. 48,Sec. 1, eff. 10/1/2024.Amended by 2018 Md. Laws, Ch. 463, Sec. 2, eff. 1/1/2020.Amended by 2018 Md. Laws, Ch. 462, Sec. 2, eff. 1/1/2020.Amended by 2017 Md. Laws, Ch. 62, Sec. 1, eff. 4/11/2017.Amended by 2016 Md. Laws, Ch. 321, Sec. 3, eff. 7/1/2016.This section is set out more than once due to postponed, multiple, or conflicting amendments.